Shmanko, Kateryna; Galle, Peter R.
Current diagnosis and systemic treatment of hepatocellular carcinoma Surveillance, diagnosis and strategies for sequence of treatmentONKOLOGE. Bd. 28. H. 4. 2022 S. 269-277
Kroese, Tiuri E.; van Hillegersberg, Richard; Schoppmann, Sebastian et al.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeEUROPEAN JOURNAL OF CANCER. Bd. 164. 2022 S. 18-29
Labenz, Christian; Toenges, Gerrit; Zheng, Ming-Hua et al.
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 98. 2022 S. 53-60
Gairing, Simon Johannes; Schleicher, Eva Maria; Labenz, Christian
Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?METABOLIC BRAIN DISEASE. 2022
Gairing, Simon Johannes; Anders, Julian; Kaps, Leonard et al.
Diagnostic accuracy of interleukin-6 serum levels in predicting minimal hepatic encephalopathy in patients with liver cirrhosisINTERNIST. Bd. 63. H. SUPPL 3. 2022 S. 330-331
Mozes, Ferenc; Lee, Jenny; Vali, Yasaman et al.
Diagnostic accuracy of non-invasive tests for cirrhotic NASH-an individual participant data meta-analysisJOURNAL OF HEPATOLOGY. Bd. 77. 2022 S. S448-S449
Mozes, Ferenc; Lee, Jenny; Vali, Yasaman et al.
Diagnostic accuracy of non-invasive tests for fibrotic NASH-An individual participant data meta-analysisJOURNAL OF HEPATOLOGY. Bd. 77. 2022 S. S452-S453
Gairing, Simon Johannes; Muller, Lukas; Penzkofer, Lea et al.
Diagnostics and treatment of hepatocellular carcinomaGASTROENTEROLOGIE. Bd. 17. H. 6. 2022 S. 403-412
Scherrer, Alexander; Zimmermann, Tobias; Riedel, Sinan et al.
Digitally Assisted Planning and Monitoring of Supportive Recommendations in Cancer PatientsIFIP Advances in Information and Communication Technology. Bd. 652. 2022 S. 401-411
Lang, Hauke; Bartsch, Fabian; Baumgart, Janine et al.
DISSECTING GENOMIC TUMOR HETEROGENEITY IN PATIENTS WITH RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA: IMPLICATIONS FOR NOVEL THERAEUTIC STRATEGIESGASTROENTEROLOGY. Bd. 162. H. 7. 2022 S. S1299-S1299